Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer


Arslan N., Tuncel M. , Kuzhan O., Alagoz E., Budakoglu B., Ozet A., ...Daha Fazla

ANNALS OF NUCLEAR MEDICINE, cilt.25, ss.406-413, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 25 Konu: 6
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1007/s12149-011-0478-y
  • Dergi Adı: ANNALS OF NUCLEAR MEDICINE
  • Sayfa Sayıları: ss.406-413

Özet

The objective of this study is to determine whether 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography (FDG-PET) imaging and quantitative PET parameters can predict outcome and differentiate patients with limited disease (LD) from extensive disease (ED) in patients with small cell lung cancer (SCLC).